Innovative Lung-on-a-Chip with Immune Function Mimics a Living Organ

A pioneering lung-on-a-chip with an active immune system offers new insights into lung disease, infection response, and personalized therapies, transforming preclinical research and reducing animal testing.
Researchers at Georgia Tech and Vanderbilt University have developed a groundbreaking lung-on-a-chip that integrates a functional immune system, marking a significant advancement in biomedical engineering. This miniature model of the human lung, constructed on a flexible polymer chip, simulates the organ’s natural behavior, including expansion, blood circulation, and immune responses. Unlike previous models, this innovative platform enables scientists to observe immune cell movement and response within lung tissue, providing deeper insights into how the lungs combat infections and inflammatory diseases.
The development was led by Ankur Singh, director of Georgia Tech's Center for Immunoengineering, who described witnessing immune cells actively migrating through the chip as a transformative moment. Alongside Krishnendu Roy and colleagues, Singh’s team faced the challenge of maintaining viable immune cells within the chip, a hurdle they successfully overcame, resulting in a model where immune responses to pathogens like influenza could be closely studied.
This model not only responds accurately to infections but also offers a more human-relevant alternative to traditional animal testing, which often fails to fully replicate human lung responses. Singh emphasized the importance of this technology for understanding severe viral infections and developing effective treatments. The platform holds promise for studying other lung diseases such as asthma, cystic fibrosis, and lung cancer, and aims toward personalized medicine by creating patient-specific chips.
This innovation could revolutionize the way respiratory diseases are researched, allowing for better prediction of treatment efficacy and reducing reliance on animal models. It exemplifies a significant step toward more accurate, human-relevant preclinical testing and could ultimately lead to improved therapies and outcomes for millions suffering from lung ailments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Cholesterol Drug Repurposed to Improve Blood-Brain Barrier and Neuropsychiatric Outcomes in DiGeorge Syndrome
Research reveals that cholesterol-lowering drugs may restore mitochondrial function and improve blood-brain barrier integrity, offering new hope for neuropsychiatric conditions in DiGeorge syndrome.
Study Finds COVID-19 School Closures in the US Were Not Cost-Effective Compared to Other Interventions
A new study reveals that COVID-19 school closures in the US were not cost-effective, highlighting the effectiveness of mask mandates, testing, and contact tracing as better alternatives for pandemic control.
AAP Releases Updated Guidelines for Assessing and Treating Patent Ductus Arteriosus in Preterm Infants
The American Academy of Pediatrics has issued updated guidelines on evaluating and managing patent ductus arteriosus in preterm infants, emphasizing evidence-based approaches and the importance of individualized care.
How Autism-Linked Genetic Mutation Contributes to PTSD-Like Fear Responses
New research uncovers how a genetic mutation associated with autism disrupts brain circuits responsible for fear extinction, leading to PTSD-like responses. The findings pave the way for targeted therapies addressing trauma in autism spectrum disorder.



